CN105296509A - 一种苹果酸脱氢酶基因rkmdh2及其重组表达载体 - Google Patents
一种苹果酸脱氢酶基因rkmdh2及其重组表达载体 Download PDFInfo
- Publication number
- CN105296509A CN105296509A CN201510782491.4A CN201510782491A CN105296509A CN 105296509 A CN105296509 A CN 105296509A CN 201510782491 A CN201510782491 A CN 201510782491A CN 105296509 A CN105296509 A CN 105296509A
- Authority
- CN
- China
- Prior art keywords
- malate dehydrogenase
- rkmdh2
- gene
- expression vector
- recombinant expression
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108010026217 Malate Dehydrogenase Proteins 0.000 title claims abstract description 45
- 238000003259 recombinant expression Methods 0.000 title claims description 9
- 239000013604 expression vector Substances 0.000 title claims description 8
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 22
- 239000002773 nucleotide Substances 0.000 claims abstract description 11
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 11
- 125000003275 alpha amino acid group Chemical group 0.000 claims abstract 2
- 102000013460 Malate Dehydrogenase Human genes 0.000 abstract description 33
- 241000588724 Escherichia coli Species 0.000 abstract description 7
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 abstract description 6
- 241000223252 Rhodotorula Species 0.000 abstract description 5
- 238000006243 chemical reaction Methods 0.000 abstract description 5
- 239000013598 vector Substances 0.000 abstract description 5
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 abstract description 4
- KHPXUQMNIQBQEV-UHFFFAOYSA-N oxaloacetic acid Chemical compound OC(=O)CC(=O)C(O)=O KHPXUQMNIQBQEV-UHFFFAOYSA-N 0.000 abstract description 4
- 240000004808 Saccharomyces cerevisiae Species 0.000 abstract description 3
- 235000011090 malic acid Nutrition 0.000 abstract description 3
- 239000001630 malic acid Substances 0.000 abstract description 2
- 102000004190 Enzymes Human genes 0.000 description 16
- 108090000790 Enzymes Proteins 0.000 description 16
- 102000004169 proteins and genes Human genes 0.000 description 12
- 230000000694 effects Effects 0.000 description 9
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 9
- 210000004027 cell Anatomy 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- 239000000872 buffer Substances 0.000 description 7
- 239000013612 plasmid Substances 0.000 description 7
- 238000004458 analytical method Methods 0.000 description 6
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 6
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 6
- 238000012408 PCR amplification Methods 0.000 description 5
- 238000001962 electrophoresis Methods 0.000 description 5
- 239000012634 fragment Substances 0.000 description 5
- 210000003000 inclusion body Anatomy 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 239000002244 precipitate Substances 0.000 description 5
- 238000000746 purification Methods 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 4
- 241000672609 Escherichia coli BL21 Species 0.000 description 4
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 4
- 229960000723 ampicillin Drugs 0.000 description 4
- 230000003321 amplification Effects 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 238000003199 nucleic acid amplification method Methods 0.000 description 4
- 239000008188 pellet Substances 0.000 description 4
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 241000007100 Rhodotorula kratochvilovae Species 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000002299 complementary DNA Substances 0.000 description 3
- 230000001086 cytosolic effect Effects 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 230000002255 enzymatic effect Effects 0.000 description 3
- 238000001976 enzyme digestion Methods 0.000 description 3
- 239000013613 expression plasmid Substances 0.000 description 3
- 238000010353 genetic engineering Methods 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 229940049920 malate Drugs 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 238000012163 sequencing technique Methods 0.000 description 3
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- 108010044467 Isoenzymes Proteins 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 239000004202 carbamide Substances 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 210000000805 cytoplasm Anatomy 0.000 description 2
- 238000004925 denaturation Methods 0.000 description 2
- 230000036425 denaturation Effects 0.000 description 2
- 238000000502 dialysis Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 208000009190 disseminated intravascular coagulation Diseases 0.000 description 2
- 239000012154 double-distilled water Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000004520 electroporation Methods 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 208000006454 hepatitis Diseases 0.000 description 2
- 238000003384 imaging method Methods 0.000 description 2
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 2
- 238000009630 liquid culture Methods 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 230000037353 metabolic pathway Effects 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 210000003470 mitochondria Anatomy 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 238000010839 reverse transcription Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 230000009261 transgenic effect Effects 0.000 description 2
- 230000004102 tricarboxylic acid cycle Effects 0.000 description 2
- 229960005486 vaccine Drugs 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- 241000620209 Escherichia coli DH5[alpha] Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 101150058595 MDH gene Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
- 241000244159 Taenia saginata Species 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000003698 anagen phase Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 238000003766 bioinformatics method Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 210000003763 chloroplast Anatomy 0.000 description 1
- 238000003759 clinical diagnosis Methods 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 238000006356 dehydrogenation reaction Methods 0.000 description 1
- 239000013578 denaturing buffer Substances 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000013399 early diagnosis Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000009585 enzyme analysis Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 230000007614 genetic variation Effects 0.000 description 1
- 230000004110 gluconeogenesis Effects 0.000 description 1
- HHLFWLYXYJOTON-UHFFFAOYSA-N glyoxylic acid Chemical compound OC(=O)C=O HHLFWLYXYJOTON-UHFFFAOYSA-N 0.000 description 1
- 210000004397 glyoxysome Anatomy 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 229940116298 l- malic acid Drugs 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 229940099690 malic acid Drugs 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000000520 microinjection Methods 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 210000003463 organelle Anatomy 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 230000003950 pathogenic mechanism Effects 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 210000002824 peroxisome Anatomy 0.000 description 1
- 238000003752 polymerase chain reaction Methods 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 230000004960 subcellular localization Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 208000004441 taeniasis Diseases 0.000 description 1
- 238000001890 transfection Methods 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
Description
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510782491.4A CN105296509B (zh) | 2015-11-16 | 2015-11-16 | 一种苹果酸脱氢酶基因rkmdh2及其重组表达载体 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510782491.4A CN105296509B (zh) | 2015-11-16 | 2015-11-16 | 一种苹果酸脱氢酶基因rkmdh2及其重组表达载体 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105296509A true CN105296509A (zh) | 2016-02-03 |
CN105296509B CN105296509B (zh) | 2019-01-22 |
Family
ID=55194338
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510782491.4A Expired - Fee Related CN105296509B (zh) | 2015-11-16 | 2015-11-16 | 一种苹果酸脱氢酶基因rkmdh2及其重组表达载体 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105296509B (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105838724A (zh) * | 2016-04-25 | 2016-08-10 | 昆明理工大学 | 一种苹果酸脱氢酶基因rgmdh1及其重组表达载体 |
CN105886517A (zh) * | 2016-04-25 | 2016-08-24 | 昆明理工大学 | 一种苹果酸脱氢酶基因rkmdh1及其重组表达载体 |
CN108624600A (zh) * | 2018-05-22 | 2018-10-09 | 昆明理工大学 | 锌指转录因子基因RkMsn4的用途 |
CN108753802A (zh) * | 2018-05-22 | 2018-11-06 | 昆明理工大学 | 一个苹果酸脱氢酶基因cimdh1及其重组表达载体 |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008130372A2 (en) * | 2006-09-28 | 2008-10-30 | Microbia, Inc. | Production of sterols in oleaginous yeast and fungi |
CN101649300A (zh) * | 2009-09-07 | 2010-02-17 | 安徽丰原发酵技术工程研究有限公司 | 一种产l-苹果酸的基因工程菌及其构建方法和应用 |
US20120149886A1 (en) * | 2008-04-10 | 2012-06-14 | Microbia, Inc. | Production of carotenoids in oleaginous yeast and fungi |
WO2015057154A2 (en) * | 2013-10-18 | 2015-04-23 | Biopetrolia Ab | ENGINEERING OF ACETYL-CoA METABOLISM IN YEAST |
CN104673809A (zh) * | 2015-01-23 | 2015-06-03 | 昆明理工大学 | 一种苹果酸脱氢酶基因及其重组表达载体 |
CN104673810A (zh) * | 2015-01-23 | 2015-06-03 | 昆明理工大学 | 一种苹果酸脱氢酶基因mimdh1及其重组表达载体 |
CN105002192A (zh) * | 2015-07-23 | 2015-10-28 | 昆明理工大学 | 一种苹果酸酶基因rkme1及其重组表达载体 |
-
2015
- 2015-11-16 CN CN201510782491.4A patent/CN105296509B/zh not_active Expired - Fee Related
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008130372A2 (en) * | 2006-09-28 | 2008-10-30 | Microbia, Inc. | Production of sterols in oleaginous yeast and fungi |
US20120149886A1 (en) * | 2008-04-10 | 2012-06-14 | Microbia, Inc. | Production of carotenoids in oleaginous yeast and fungi |
CN101649300A (zh) * | 2009-09-07 | 2010-02-17 | 安徽丰原发酵技术工程研究有限公司 | 一种产l-苹果酸的基因工程菌及其构建方法和应用 |
WO2015057154A2 (en) * | 2013-10-18 | 2015-04-23 | Biopetrolia Ab | ENGINEERING OF ACETYL-CoA METABOLISM IN YEAST |
CN104673809A (zh) * | 2015-01-23 | 2015-06-03 | 昆明理工大学 | 一种苹果酸脱氢酶基因及其重组表达载体 |
CN104673810A (zh) * | 2015-01-23 | 2015-06-03 | 昆明理工大学 | 一种苹果酸脱氢酶基因mimdh1及其重组表达载体 |
CN105002192A (zh) * | 2015-07-23 | 2015-10-28 | 昆明理工大学 | 一种苹果酸酶基因rkme1及其重组表达载体 |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105838724A (zh) * | 2016-04-25 | 2016-08-10 | 昆明理工大学 | 一种苹果酸脱氢酶基因rgmdh1及其重组表达载体 |
CN105886517A (zh) * | 2016-04-25 | 2016-08-24 | 昆明理工大学 | 一种苹果酸脱氢酶基因rkmdh1及其重组表达载体 |
CN105886517B (zh) * | 2016-04-25 | 2019-07-16 | 昆明理工大学 | 一种苹果酸脱氢酶基因rkmdh1及其重组表达载体 |
CN105838724B (zh) * | 2016-04-25 | 2019-09-27 | 昆明理工大学 | 一种苹果酸脱氢酶基因rgmdh1及其重组表达载体 |
CN108624600A (zh) * | 2018-05-22 | 2018-10-09 | 昆明理工大学 | 锌指转录因子基因RkMsn4的用途 |
CN108753802A (zh) * | 2018-05-22 | 2018-11-06 | 昆明理工大学 | 一个苹果酸脱氢酶基因cimdh1及其重组表达载体 |
CN108753802B (zh) * | 2018-05-22 | 2021-07-16 | 昆明理工大学 | 一个苹果酸脱氢酶基因cimdh1及其重组表达载体 |
Also Published As
Publication number | Publication date |
---|---|
CN105296509B (zh) | 2019-01-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104673809B (zh) | 一种苹果酸脱氢酶基因及其重组表达载体 | |
CN104673810A (zh) | 一种苹果酸脱氢酶基因mimdh1及其重组表达载体 | |
CN106929521B (zh) | 一种醛酮还原酶基因重组共表达载体、工程菌及其应用 | |
CN106591270B (zh) | 一株定点突变改造的基因工程精氨酸脱亚胺酶 | |
CN105296509A (zh) | 一种苹果酸脱氢酶基因rkmdh2及其重组表达载体 | |
CN105505846A (zh) | 表面展示谷氨酸脱氢酶的重组芽孢及其构建方法与应用 | |
CN103114110B (zh) | 利用固定化酶合成胆红素的方法 | |
CN105838724B (zh) | 一种苹果酸脱氢酶基因rgmdh1及其重组表达载体 | |
CN104130984B (zh) | 作用于杂色曲菌素的黄曲霉毒素氧化酶 | |
CN108998462B (zh) | 含锰离子重组蛋白的大肠杆菌表达系统及其应用方法 | |
JP5791025B2 (ja) | ラッカーゼ活性を有する耐熱性タンパク質、当該タンパク質をコードする核酸分子、当該タンパク質の製造方法 | |
CN105002192B (zh) | 一种苹果酸酶基因rkme1及其重组表达载体 | |
CN105886517B (zh) | 一种苹果酸脱氢酶基因rkmdh1及其重组表达载体 | |
CN106754776A (zh) | 一种催化木糖的比酶活提高的葡萄糖脱氢酶突变体 | |
CN107904222B (zh) | 一种热稳定性提高的l-氨基酸脱氨酶突变体及其构建方法 | |
CN103103234A (zh) | 利用固定化酶合成烟酰胺腺嘌呤二核苷酸(nad)的方法 | |
CN105349557B (zh) | 一种苹果酸酶基因rkme2及其重组表达载体 | |
CN108753802B (zh) | 一个苹果酸脱氢酶基因cimdh1及其重组表达载体 | |
CN109337879A (zh) | 一种苹果酸脱氢酶PbMDH及其编码序列和应用 | |
CN108977455A (zh) | 用于生产草酸脱羧酶的重组质粒、大肠杆菌表达系统及方法和应用 | |
CN109022471B (zh) | 生产草酸氧化酶的大肠杆菌表达系统、草酸氧化酶的生产方法及其应用 | |
CN104152430B (zh) | 一种催化活性提高且最适pH降低的L-阿拉伯糖异构酶的突变体酶D478N | |
CN106636019B (zh) | Sortase A介导的(S)-羰基还原酶寡聚体高效催化(S)-苯基乙二醇的合成 | |
CN115261296A (zh) | 一种表达氨肽酶m1ap的重组大肠杆菌及构建方法 | |
CN101864448A (zh) | 大肠杆菌苹果酸脱氢酶基因mdh的克隆、高效表达及酶学性质研究 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information |
Inventor after: Zhang Qi Inventor after: Li Shan Inventor after: Tiger Inventor after: Ji Xiuling Inventor after: Wei Yunlin Inventor after: Lin Lianbing Inventor before: Zhang Qi Inventor before: Tiger Inventor before: Ji Xiuling Inventor before: Wei Yunlin Inventor before: Lin Lianbing |
|
CB03 | Change of inventor or designer information | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20190122 |
|
CF01 | Termination of patent right due to non-payment of annual fee |